Glenmark Pharmaceuticals’ Q2FY27 net profit fell 56.8% to ₹263.83 crore, while revenue declined 29.8% to ₹4,247.32 crore, with earnings dragged by exceptional items.
The post Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57% appeared first on Home Page.
